Coronary artery disease (CAD) frequently coexists with severe aortic stenosis (AS) and is present in up to 50 % of patients undergoing transcatheter aortic valve replacement (TAVR).1 Given its prognostic implications and the overlap in symptoms between CAD and AS, accurate assessment of CAD is an important component of pre-TAVR evaluation. While invasive coronary angiography (ICA) remains the gold standard, there is growing evidence for coronary computed tomography angiography (CCTA) in evaluat…